Výsledky vyhledávání - "Sameer Kotak"

Akademický článek

Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis

Autor: George W. Reed, David H. Collier, Andrew S. Koenig, Katherine C. Saunders, Dimitrios A. Pappas, Heather J. Litman, Joel M. Kremer, Sameer Kotak

Publikováno v: Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-8 (2017)

Abstract Background We examined models to predict disease activity transitions from moderate to low or severe and associated factors in patients with rheumatoid arthritis (RA). Methods Data from RA patients enrolled in the Corrona registry (October 2

Externí odkaz: https://doaj.org/article/15ba95ac9b944dc89ed9cf857cda8def

Zobrazit plný text záznamu

Akademický článek

Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.

Autor: Robert J Moots, Ricardo M Xavier, Chi Chiu Mok, Mahboob U Rahman, Wen-Chan Tsai, Mustafa H Al-Maini, Karel Pavelka, Ehab Mahgoub, Sameer Kotak, Joan Korth-Bradley, Ron Pedersen, Linda Mele, Qi Shen, Bonnie Vlahos

Publikováno v: PLoS ONE, Vol 12, Iss 6, p e0179308 (2017)

[This corrects the article DOI: 10.1371/journal.pone.0175207.].

Externí odkaz: https://doaj.org/article/ae31931fea8a46669c33dfddcbc80e96

Zobrazit plný text záznamu

Akademický článek

The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.

Publikováno v: PLoS ONE, Vol 12, Iss 4, p e0175207 (2017)

OBJECTIVE:To assess the incidence of anti-drug antibodies (ADA) in patients with rheumatoid arthritis (RA) treated with the TNF inhibitors etanercept (ETN), adalimumab (ADL), or infliximab (IFX), and determine the potential relationship with trough d

Externí odkaz: https://doaj.org/article/6af16e2d555b4839b6545a44c5ff9ea2

Zobrazit plný text záznamu

Maintenance of remission with combination etanercept–DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access

Autor: Qi Shen, Sameer Kotak, Karel Pavelka, Radu Vasilescu, Mahboob Rahman, Evgeny Nasonov, Mustafa Al-Maini, Andrew Dinh, Ehab Mahgoub, Cristiano A. F. Zerbini, Dmitry Karateev, Ronald Pedersen, Nurullah Akkoc, Bonnie Vlahos

Publikováno v: Rheumatology International. 37:1469-1479

In this transglobal, randomized, double-blind, placebo-controlled, treat-to-target study, the maintenance of efficacy was compared between biologic–and biologic-free–disease-modifying antirheumatic drug (DMARD) combination regimens after low dise

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c970301a85571b50f5d25f95087fba98
https://doi.org/10.1007/s00296-017-3749-7

Zobrazit plný text záznamu

Efficacy and safety of etanercept in patients from Latin America, Central Europe and Asia with early non-radiographic axial spondyloarthritis

Autor: Wen-Chan Tsai, James Cheng-Chung Wei, Sameer Kotak, Gustavo Citera, Lyndon John Q Llamado

Publikováno v: International Journal of Rheumatic Diseases. 21:1443-1451

Aim To evaluate etanercept in patients from Latin America, Central/Eastern Europe, and Asia with non-radiographic axial spondyloarthritis (nr-axSpA). Methods A subset analysis was performed on nr-axSpA patients from Argentina, Colombia, the Czech Rep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf8556743c3a83e8a8f9f0e13336afb8
https://doi.org/10.1111/1756-185x.12973

Zobrazit plný text záznamu

The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis

Autor: Bonnie Vlahos, Sameer Kotak, Jack F. Bukowski, Stefanie Gaylord, Jean Dudler, Ron Pedersen, Theresa Williams, Hasan Tahir, Piotr Wiland, Douglas J. Veale

Publikováno v: The Journal of Rheumatology. 43:1268-1277

Objective.An analysis of a clinical trial to assess the effects of treatment reduction and withdrawal on patient-reported outcomes (PRO) in patients with early, moderate to severe rheumatoid arthritis (RA) who achieved 28-joint Disease Activity Score

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::364708ad37fe7f4404c8de2a588a0fe6
https://doi.org/10.3899/jrheum.151179

Zobrazit plný text záznamu

Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia

Autor: Nemanja Damjanov, Khalid Shirazy, Sameer Kotak, Lyndon John Q Llamado, Eustratios Bananis, Waleed Al Shehhi, Ehab Mahgoub, Rubén Burgos-Vargas, Annette Szumski, Feng Huang

Publikováno v: Rheumatology International. 36:643-651

Despite the demonstrated efficacy of etanercept for the treatment of ankylosing spondylitis (AS), sulfasalazine is often prescribed, especially in countries with limited access to biologic agents. The objective of this subset analysis of the ASCEND t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d3604eab535a222f07ec0c731961c4
https://doi.org/10.1007/s00296-016-3452-0

Zobrazit plný text záznamu

Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumatic Drugs in the Latin American Region

Autor: Renato Guzmán, Daniel A. Machado, Ricardo Machado Xavier, Bonnie Vlahos, Qi Shen, Sameer Kotak, Jesus A. Simon, Linda Mele, Ronald Pedersen

Publikováno v: The Open Rheumatology Journal
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS

Background:Although long-term data are available from biologic studies in North American/European populations with rheumatoid arthritis (RA), long-term findings in Latin American RA populations are limited.Objective:To examine long-term safety/effica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0030d9025decb9d239d1c9321f069ea2
http://europepmc.org/articles/PMC4780479

Zobrazit plný text záznamu

The impact of rheumatoid arthritis on work and predictors of overall work impairment from three therapeutic scenarios

Autor: Thomas V. Jones, Sameer Kotak, Andrew S Koenig, Wenzhi Li, Vibeke Strand

Publikováno v: International Journal of Clinical Rheumatology. 10:317-328

Aim: To examine the effects of three treatment scenarios in rheumatoid arthritis (RA) on work and to determine potential predictors of work impairment. Materials & methods: Moderate RA patients received etanercept 50 mg weekly plus methotrexate (E50/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::432973dd3ba8468ac5d50179cbf60c6e
https://doi.org/10.2217/ijr.15.40

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání